State of Wisconsin Investment Board
RAPP

State of Wisconsin Investment Board’s Rapport Therapeutics RAPP Stock Holding History

State of Wisconsin Investment Board’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$748K Buy
23,914
+15,617
+188% +$439K ﹤0.01% 1811
2025
Q4 		$252K Buy
+8,297
New +$230K ﹤0.01% 2218

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

State of Wisconsin Investment Board's RAPP Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Rapport Therapeutics (RAPP) stake by 188% in Q1 2026, buying an estimated $439K and bringing the position to 23,914 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

State of Wisconsin Investment Board first reported a position in RAPP in Q4 2025 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

  • State of Wisconsin Investment Board held 23,914 shares of Rapport Therapeutics worth $748K as of Q1 2026.
  • State of Wisconsin Investment Board bought 15,617 Rapport Therapeutics shares in Q1 2026, an estimated $439K.
  • Rapport Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1811 holding.
  • State of Wisconsin Investment Board first reported a position in Rapport Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.